FrancophonIA/ELRC3.0 huggingface dataset:
English: • antifungal medicines (such as ketoconazole or itraconazole), medicines used for HIV-AIDS (such as ritonavir) or medicines used after transplants to prevent organ rejection (such as cyclosporin) because these medicines can increase the blood concentration of Silodyx.
Slovenian: • zdravila proti glivicam (kot sta ketokonazol ali itrakonazol), zdravila za zdravljenje okužbe z virusom HIV/AIDS (kot je ritonavir) ali zdravila, ki se uporabljajo po presaditvi organov za preprečevanje zavrnitve organa (kot je ciklosporin), ker ta zdravila lahko zvišajo koncentracijo zdravila Silodyx v krvi.
English: A starting dose of 4 mg once daily is recommended in patients with moderate renal impairment (CLCR ≥ 30 to < 50 mL/min), which may be increased to 8 mg once daily after one week of treatment, depending on the individual patient's response.
Slovenian: Pri bolnikih z zmerno okvaro delovanja ledvic (CLCR ≥ 30 do < 50 ml/min) je priporočljivo uporabiti začetni odmerek 4 mg enkrat na dan, ki se ga glede na odziv posameznega bolnika po enem tednu zdravljenja lahko poveča na 8 mg enkrat na dan.
English: ZAMBON nv-sa Tél/Tel: + 32 2 777 02 00
Slovenian: Luxembourg/Luxemburg ZAMBON nv-sa Tél/Tel: + 32 2 777 02 00
English: You may take your capsule later the same day if you have forgotten to take it earlier.
Slovenian: Če ste tekom dneva pozabili vzeti kapsulo, jo vzemite pozneje istega dne.
English: Silodyx is used in adult men to treat the urinary symptoms associated with benign enlargement of the prostate (prostatic hyperplasia), such as:
Slovenian: Zdravilo Silodyx se pri odraslih moških uporablja za zdravljenje simptomov mokrenja, ki so povezani z nenevarnim povečanjem prostate (hiperplazijo prostate), kot na primer:
English: Following oral administration of 14C-labelled silodosin, the recovery of radioactivity after 7 days was approximately 33.5% in urine and 54.9% in faeces.
Slovenian: C-označenega silodozina je bilo po 7 dneh v urinu zaznane približno 33,5% in v fecesu približno 54,9% vnesene radioaktivnosti.
English: • Since a benign enlargement of the prostate and prostate cancer may present the same symptoms, your doctor will check you for prostate cancer before starting treatment with Silodyx.
Slovenian: • Ker imata nenevarno povečanje prostate in rak prostate lahko enake simptome, vas bo zdravnik pred pričetkom zdravljenja z zdravilom Silodyx poslal na kontrolni pregled za raka prostate.
English: The active substance is silodosin.
Slovenian: Zdravilna učinkovina je silodozin.
English: • medicines used for treating problems in getting or keeping an erection (such as sildenafil or tadalafil), since the concomitant use with Silodyx might lead to a slight decrease in blood pressure.
Slovenian: • zdravila za zdravljenje težav z nastankom ali ohranitvijo erekcije (kot sta sildenafil ali tadalafil), ker uporaba skupaj z zdravilom Silodyx lahko vodi v rahlo znižanje krvnega tlaka.
English: • medicines which lower blood pressure (in particular, medicines called alpha1-blockers, such as prazosin or doxazosin) as there may be the potential risk that the effect of these medicines is increased whilst taking Silodyx.
Slovenian: • zdravila za zniževanje krvnega tlaka (zlasti zdravila, imenovana zaviralci alfa1 kot sta prazosin ali doksazosin), ker obstaja tveganje, da se ob jemanju zdravila Silodyx učinek teh zdravil okrepi.
English: Capsule content Starch, pregelatinised (maize) Mannitol (E421) Magnesium stearate Sodium laurilsulfate
Slovenian: Vsebina kapsule predgelirani škrob (koruzni) manitol (E421) magnezijev stearat natrijev lavrilsulfat
English: If you have taken more than one capsule, inform your doctor as soon as possible.
Slovenian: Če ste vzeli večji odmerek zdravila Silodyx, kot bi smeli Če ste vzeli več kot eno kapsulo, čimprej obvestite svojega zdravnika.
English: In the active-controlled clinical study conducted in Europe, silodosin 8 mg once daily was shown to be non inferior to tamsulosin 0.4 mg once daily: the adjusted mean difference (95% CI) in the IPSS Total Score between treatments in the per-protocol population was 0.4 (-0.4 to 1.1).
Slovenian: V z zdravilno učinkovino nadzorovani klinični študiji, izpeljani v Evropi, se je pokazalo, da 8 mg silodozina enkrat na dan ni dajalo slabših rezultatov od 0,4 mg tamsulozina enkrat na dan: prilagojena povprečna razlika (95% CI) v rezultatu vprašalnika IPSS med posameznimi s protokolom določenimi populacijami je znašala 0,4 (-0,4 do 1,1).
English: In a Phase II dose-finding, double-blind, placebo-controlled clinical study with silodosin 4 or 8 mg once daily, a greater improvement in American Urologic Association (AUA) symptom index score was observed with silodosin 8 mg (-6.8 ± 5.8, n = 90; p = 0.0018) and silodosin 4 mg (-5.7 ± 5.5, n = 88; p = 0.0355) as compared to placebo (-4.0 ± 5.5, n = 83).
Slovenian: V dvojno slepi s placebom nadzorovani klinični študiji Faze II za določanje odmerka s 4 ali 8 mg silodozinom enkrat na dan je bilo v primerjavi s placebom (-4,0 ± 5,5, n = 83) pri uporabi 8 mg silodozina (-6,8 ± 5,8, n = 90; p = 0,0018) in 4 mg silodozina (-5,7 ± 5,5, n = 88; p = 0,0355) opaženo večje izboljšanje točkovnega rezultata po vprašalniku Ameriškega urološkega združenja (AUA-American Urologic Association).
English: In all studies, patients treated with silodosin had a greater decrease in both storage (irritative) and voiding (obstructive) symptoms of BPH as compared to placebo as assessed after 12 weeks of treatment.
Slovenian: V vseh študijah so imeli bolniki, zdravljeni s silodozinom, v primerjavi s placebom bolj izraženo izboljšanje iritacijskih in obstrukcijskih simptomov BHP, kar so ocenili po 12 tednih zdravljenja.
English: IPSS Irritative symptoms
Slovenian: Iritacijski simptomi
English: Over 800 patients with moderate to severe symptoms of BPH (International Prostate Symptom Score, IPSS, baseline value ≥ 13) received silodosin 8 mg once daily in two Phase III placebo-controlled clinical studies conducted in the United States and in one placebo- and active-controlled clinical study conducted in Europe.
Slovenian: Preko 800 bolnikov z zmernimi do hudimi simptomi BHP (IPSS - International Prostate Symptom Score; izhodiščna vrednost ≥ 13) je v dveh s placebom nadzorovanih kliničnih študijah Faze III v Združenih državah Amerike in v eni s placebom in z zdravilno učinkovino nadzorovani klinični študiji, izpeljani v Evropi, prejemalo 8 mg silodozin enkrat na dan.
English: This medicinal product contains less than 1 mmol sodium (23 mg) per capsule, that is to say essentially ‘sodium-free'.
Slovenian: Natrij To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na kapsulo, kar v bistvu pomeni ‘brez natrija'.
English: Allergic-type reactions including facial swelling, swollen tongue and pharyngeal oedema1
Slovenian: Bolezni imunskega sistema alergijske reakcije, vključno z oteklostjo obraza, oteklostjo jezika in faringealnim edemom1
English: What Silodyx looks like and contents of the pack
Slovenian: Izgled zdravila Silodyx in vsebina pakiranja
English: • Runny or blocked nose
Slovenian: • izcedek iz nosu ali zamašen nos
English: Urorec may reduce the amount of sperm, and so could temporarily affect your ability to father a child.
Slovenian: Zdravilo Silodyx lahko zmanjša količino sperme, zaradi česar lahko začasno vpliva na sposobnost zaploditve otroka.
English: There is no relevant use of Silodyx in the paediatric population for the indication of benign prostatic hyperplasia (BPH).
Slovenian: Zdravilo Silodyx ni namenjeno za uporabo pri pediatrični populaciji za navedeno benigne hiperplazije prostate (BHP).
English: If you forget to take Silodyx
Slovenian: Če ste pozabili vzeti zdravilo Silodyx
English: IFIS (a variant of small pupil syndrome) has been observed during cataract surgery in some patients on α1-blockers or previously treated with α1-blockers.
Slovenian: Medoperacijski sindrom ohlapne šarenice (IFIS - Intraoperative Floppy Iris Syndrome) Med operacijo sive mrene so pri nekaterih bolnikih, ki so bili sočasno ali predhodno zdravljeni z zaviralci α1 receptorjev, opazili IFIS (različica sindroma majhne zenice).
English: Silodosin was evaluated at doses of up to 48 mg/day in healthy male subjects.
Slovenian: Uporaba silodozina je bila pri zdravih moških ovrednotena vse do odmerka 48 mg/dan.
English: Intraoperative Floppy Iris Syndrome (IFIS) IFIS has been reported during cataract surgery (see section 4.4).
Slovenian: Medoperacijski sindrom ohlapne šarenice (IFIS) Poročali so, da je pri operacijah sive mrene prišlo do sindroma IFIS (glejte poglavje 4.4).
English: Silodyx is selective for the receptors located in the prostate, bladder and urethra.
Slovenian: Zdravilo Silodyx se selektivno veže na receptorje, ki se nahajajo v prostati, mehurju in sečnici.
English: The treatment with Silodyx may lead to an abnormal ejaculation (decrease in the amount of semen released during sex) that may temporarily affect male fertility.
Slovenian: • Zdravljenje z zdravilom Silodyx lahko povzroči nenormalno ejakulacijo (zmanjšanje količine sperme, izločene pri spolnem odnosu), kar lahko začasno prizadene moško plodnost.
English: If you stop taking Silodyx
Slovenian: Če ste prenehali jemati zdravilo Silodyx
English: Ejaculatory disorders, including retrograde ejaculation, anejaculation
Slovenian: Motnje reprodukcije in dojk motnje ejakulacije, vključno z retrogradno ejakulacijo, anejakulacijo erektilna disfunkcija
English: No dose adjustment is required for patients with mild renal impairment (CLCR ≥ 50 to ≤ 80 mL/min).
Slovenian: Pri bolnikih z blago okvaro delovanja ledvic (CLCR ≥ 50 do ≤ 80 ml/min) prilagoditev odmerka ni potrebna.
English: The recommended dose is one capsule of Silodyx 8 mg daily.
Slovenian: Priporočeni odmerek je ena kapsula zdravila Silodyx 8 mg na dan.
English: For this purpose Silodyx 4 mg hard capsules are available.
Slovenian: V ta namen je na voljo zdravilo Silodyx 4 mg trde kapsule.
English: Silodyx 4 mg are yellow, opaque, hard gelatin capsules, size 3 (approximately 15.9 x 5.8 mm).
Slovenian: Zdravilo Silodyx 4 mg so rumene, neprozorne, trde želatinske kapsule, velikost 3 (približno 15,9 mm x 5,8 mm).
English: Yellow, opaque, hard gelatin capsule, size 3 (approximately 15.9 x 5.8 mm).
Slovenian: Rumena, neprozorna, trda želatinska kapsula velikosti 3 (približno 15,9 mm x 5,8 mm).
English: Silodyx 8 mg are white, opaque, hard gelatin capsules, size 0 (approximately 21.7 x 7.6 mm).
Slovenian: Zdravilo Silodyx 8 mg so bele, neprozorne, trde želatinske kapsule, (velikost 0, približno 21,7 mm x 7,6 mm).
English: Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Slovenian: Preobčutljivost na zdravilno učinkovino ali katerokoli pomožno snov, navedeno v poglavju 6.1. 4.4 Posebna opozorila in previdnostni ukrepi
English: White, opaque, hard gelatin capsule, size 0 (approximately 21.7 x 7.6 mm).
Slovenian: Bela, neprozorna, trda želatinska kapsula velikosti 0 (približno 21,7 mm x 7,6 mm).
English: The use of silodosin in patients with severe renal impairment (CLCR <30 ml/min) is not recommended (see sections 4.2 and 5.2).
Slovenian: Uporaba silodozina pri bolnikih s hudo okvaro delovanja ledvic (CLCR < 30 ml/min) ni priporočljiva (glejte poglavji 4.2 in 5.2).
English: What Silodyx is and what it is used for What Silodyx is
Slovenian: Kaj je zdravilo Silodyx in za kaj ga uporabljamo
English: Takeda Italia S.p.A. Tel: +39 06 502601
Slovenian: Tel: + 39 06 502601
English: How to take Silodyx
Slovenian: Kako jemati zdravilo Silodyx
English: Alpha-blockers There is inadequate information about the safe use of silodosin in association with other α-adrenoreceptor antagonists.
Slovenian: Podatki o varni uporabi silodozina v povezavi z drugimi antagonisti α-adrenergičnih receptorjev so nezadostni.
English: Almirall, S.A. Tel: +34 93 291 30 00
Slovenian: Tel: +34 93 291 30 00
English: Injury, poisoning and procedural complication
Slovenian: Poškodbe in zastrupitve in zapleti pri posegih medoperacijs ki sindrom ohlapne šarenice
English: As no data are available, the use in patients with severe hepatic impairment is not recommended (see sections 4.4 and 5.2).
Slovenian: Zaradi pomanjkanja podatkov uporaba pri bolnikih s hudo okvaro delovanja jeter ni priporočljiva (glejte poglavji 4.4 in 5.2).
English: Dialysis is unlikely to be of significant benefit since silodosin is highly (96.6%) protein bound.
Slovenian: Zaradi močne vezave (96,6%) silodozina na beljakovine je malo verjetno, da bi bila dializa zelo koristna.
English: In patients with severe renal impairment administration of Silodyx is not recommended.
Slovenian: Pri bolnikih s hudo okvaro delovanja ledvic uporaba zdravila Silodyx ni priporočljiva.
English: The recommended dose is one capsule of Silodyx 8 mg per day by oral administration.
Slovenian: Priporočeni odmerek je ena kapsula zdravila Silodyx 8 mg enkrat na dan peroralno (zaužita skozi usta).
English: Silodyx is not intended for use by women.
Slovenian: Nosečnost in dojenje Zdravilo Silodyx ni namenjeno ženskam.
English: Silodyx 8 mg hard capsules Each hard capsule contains 8 mg silodosin.
Slovenian: Silodyx 8 mg trde kapsule Ena trda kapsula vsebuje 8 mg silodozina.
English: Talk to your doctor or pharmacist before taking Silodyx
Slovenian: Pred začetkom jemanja zdravila Silodyx se posvetujte z zdravnikom ali farmacevtom.
English: Ask your doctor whether or not you should postpone or temporarily stop taking Silodyx when undergoing cataract surgery.
Slovenian: Če se pripravljate na operacijo sive mrene, vprašajte svojega zdravnika, če lahko odložite začetek jemanja ali začasno prenehate z jemanjem zdravila Silodyx.
English: Skin rash1, Pruritus1
Slovenian: Bolezni kože in podkožja kožni izpušèaj pruritus1
English: Silodyx 4 mg hard capsules Silodyx 8 mg hard capsules
Slovenian: Silodyx 4 mg trde kapsule Silodyx 8 mg trde kapsule
English: Each hard capsule contains 4 mg silodosin.
Slovenian: Ena trda kapsula vsebuje 4 mg silodozina.
English: Steady state levels of digoxin, a substrate of P-glycoprotein, were not significantly affected by co-administration with silodosin 8 mg once daily.
Slovenian: Sočasna uporaba 8 mg silodozina enkrat na dan ni imela pomembnejšega vpliva na koncentracijo digoksina, substrata za P-glikoprotein, v stanju dinamičnega ravnovesja.
English: What Silodyx is used for
Slovenian: Za kaj uporabljamo zdravilo Silodyx
English: Zambon Nederland B.V. Tel: + 31 33 4504370
Slovenian: Tel: + 31 33 4504370
English: Each hard capsule contains 8 mg silodosin.
Slovenian: Ena trda kapsula vsebuje 8 mg silodozina.
English: Silodyx 8 mg hard capsules silodosin
Slovenian: Silodyx 8 mg trde kapsule silodozin
English: Silodyx 4 mg hard capsules silodosin
Slovenian: Silodyx 4 mg trde kapsule silodozin
English: Silodyx 4 mg hard capsules
Slovenian: Silodyx 4 mg trde kapsule
English: Silodyx 8 mg hard capsules
Slovenian: Silodyx 8 mg trde kapsule
English: Silodyx 4 mg hard capsules Each hard capsule contains 4 mg silodosin.
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Silodyx 4 mg trde kapsule Ena trda kapsula vsebuje 4 mg silodozina.
English: Contents of the pack and other information What Silodyx contains
Slovenian: Shranjevanje zdravila Silodyx Vsebina pakiranja in dodatne informacije
English: How to store Silodyx
Slovenian: Shranjevanje zdravila Silodyx
English: Silodyx 4 mg and 8 mg hard capsules
Slovenian: 6.1 Seznam pomožnih snovi Silodyx 4 mg in 8 mg trde kapsule
English: Vascular disorders
Slovenian: Blokatorji alfa
English: Outcome of a procedure under Article 13 of Regulation (EC) 1234/2008
Slovenian: Izid postopka v skladu s členom 13 Direktive (ES) 1234/2008
English: The European Commission issued a decision on 10 April 2013.
Slovenian: Evropska komisija je sklep izdala dne 10. aprila 2013.
English: In December 2011, the company applied for an additional use in Germany.
Slovenian: Decembra 2011 je podjetje vložilo vlogo za dodatno uporabo v Nemčiji.
English: The Committee looked at the study presented by the company to support its application.
Slovenian: Odbor je pregledal študijo, ki jo je podjetje predložilo v podporo vlogi.
English: On 13 December 2012, Germany referred the matter to the CHMP for arbitration.
Slovenian: Nemčija je 13. decembra 2012 zadevo napotila na odbor CHMP v arbitražo.
English: Why was Kantos Master reviewed?
Slovenian: Zakaj je bilo zdravilo Kantos Master ponovno preučeno?
English: On 17 January 2013, the European Medicines Agency completed an arbitration procedure for Kantos Master and associated names.
Slovenian: Evropska agencija za zdravila je 17. januarja 2013 končala postopek arbitraže za zdravilo Kantos Master in povezana imena.
English: Kantos Master is authorised under a mutual recognition procedure based on an initial authorisation granted by Germany.
Slovenian: Zdravilo Kantos Master je odobreno s postopkom medsebojnega priznavanja na podlagi začetnega dovoljenja, ki ga je odobrila Nemčija.
English: However, the Member States were unable to reach agreement on whether to accept this indication for Kantos Master.
Slovenian: Vendar države članice niso uspele doseči soglasja v zvezi s sprejetjem omenjene indikacije za zdravilo Kantos Master.
English: What is Kantos Master?
Slovenian: Kaj je zdravilo Kantos Master?
English: Kantos Master is used as maintenance therapy in patients who have asthma.
Slovenian: Zdravilo Kantos Master se uporablja kot vzdrževalno zdravljenje pri bolnikih z astmo.
English: Kantos Master is marketed in all EU Member States except Czech Republic, Ireland, Malta Portugal and Slovakia under the names Kantos, Formodual, Foster, Inuxair, Innovair and associated names.
Slovenian: Zdravilo Kantos Master se trži v vseh državah članicah EU, razen na Češkem, Irskem, Malti, Portugalskem in Slovaškem, pod imeni Kantos, Formodual, Foster, Inuxair, Innovair in povezanimi imeni.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) had been asked to arbitrate on a requested change to the marketing authorisation for these medicines to include a new use as rescue therapy for acute relief of asthma symptoms.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP), ki deluje pri agenciji, je bil pozvan, da presodi o zahtevani spremembi dovoljenja za promet za ta zdravila, s katero bi k dovoljenju vključili novo uporabo zdravil kot rešilno zdravljenje za akutno lajšanje simptomov astme.
English: The CHMP noted that MART was not compared with the standard of care according to current guidelines, but agreed that there was no evidence that patients in the comparison group had been undertreated, as patients in both groups had shown clinical benefit from their maintenance treatment.
Slovenian: Odbor CHMP je zabeležil, da primerjava sheme MART s standardno nego ni bila izvedena v skladu s trenutnimi smernicami, vendar se je strinjal, da ne obstaja noben dokaz, da so bili bolniki v primerjalni skupini neustrezno obravnavani, saj so pri bolnikih v obeh skupinah zabeležili klinične koristi vzdrževalnega zdravljenja.
English: Based on the evaluation of the currently available data and the scientific discussion within the Committee, the CHMP agreed that Kantos Master has been shown to reduce the risk of severe exacerbation of asthma and prolong the time between exacerbations when part of the dose is given on an as-needed basis as MART.
Slovenian: Na osnovi vrednotenja trenutno razpoložljivih podatkov in znanstvene razprave znotraj Odbora se je odbor CHMP strinjal, da zdravilo Kantos Master zmanjša tveganje za pojav hude eksacerbacije astme in podaljša čas med eksacerbacijami, ko se del odmerka daje po potrebi kot shema MART.
English: The CHMP therefore concluded that the benefits of Kantos Master for MART outweigh its risks and recommended that the marketing authorisation be granted in Germany and the concerned Member States.
Slovenian: Odbor CHMP je zato zaključil, da so koristi zdravila Kantos Master za shemo MART večje od z njim povezanih tveganj, in priporočil, da se dovoljenje za promet z zdravilom odobri v Nemčiji in zadevnih državah članicah.
English: It also took note of relevant literature supporting the principle of using such a combination of corticosteroid and long-acting bronchodilator (beclometasone and formoterol) for MART.
Slovenian: Odbor je prav tako upošteval ustrezno literaturo, ki podpira načelo uporabe takšne kombinacije kortikosteroida in bronhodilatatorja z dolgim delovanjem (beklometazon in formoterol) za shemo MART.
English: The Committee concluded that the benefits of Kantos Master outweigh its risks in the new use and the change to the marketing authorisation can be granted in Germany and the following Member States: Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Greece, Hungary, Italy, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Poland, Romania, Slovenia, Spain, Sweden and the United Kingdom.
Slovenian: Odbor je zaključil, da so koristi zdravila Kantos Master večje od z njim povezanih tveganj pri novi uporabi in da se lahko sprememba dovoljenja za promet z zdravilom odobri v Nemčiji in naslednjih državah članicah: Avstriji, Belgiji, Bolgariji, na Cipru, Danskem, v Estoniji, na Finskem, v Franciji, Grčiji, na Madžarskem, v Italiji, Latviji, Litvi, Luksemburgu, na Nizozemskem, Norveškem, Poljskem, v Romuniji, Sloveniji, Španiji, na Švedskem in v Združenem kraljestvu.
English: The company that makes the medicine is Chiesi.
Slovenian: Zdravilo proizvaja podjetje Chiese.
English: Questions and answers on Kantos Master and associated names (beclomethasone dipropionate / formoterol fumarate, inhaler) EMA/21628/2013 rev.1
Slovenian: Vprašanja in odgovori v zvezi z zdravilom Kantos Master in povezanimi imeni (beklometazon dipropionat / formoterol fumarat, inhalator) EMA/21628/2013 rev.1
English: Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden and the United Kingdom (the ‘concerned Member States').
Slovenian: Bolgariji, na Cipru, Danskem, v Estoniji, na Finskem, v Franciji, Grčiji, na Madžarskem, v Italiji, Latviji, Litvi, Luksemburgu, na Nizozemskem, Norveškem, Poljskem, Portugalskem, v Romuniji, na Slovaškem, v Sloveniji, Španiji, na Švedskem in v Združenem kraljestvu („zadevne države članice ).
English: Kantos Master is a medicine that contains two active substances: beclomethasone dipropionate, a corticosteroid (a medicine that reduces inflammation), and formoterol fumarate, a bronchodilator (a medicine that opens the airways, allowing easier breathing) with a long duration of action.
Slovenian: Kantos Master je zdravilo, ki vsebuje dve zdravilni učinkovini: kortikosteroid beklometazon dipropionat (zdravilo, ki zmanjšuje vnetje) in bronhodilatator formoterol fumarat (zdravilo, ki odpira dihalne poti in s tem olajša dihanje) z dolgim časom učinkovanja.
English: The application was for the use of Kantos Master for both maintenance therapy of asthma and for relief of symptoms when they arise instead of the use of a separate short-acting bronchodilator (maintenance and reliever therapy, or MART).
Slovenian: Vloga se je nanašala na uporabo zdravila Kantos Master tako za vzdrževalno zdravljenje astme kot tudi za lajšanje simptomov, ko se razvijejo, namesto uporabe ločenega bronhodilatatorja s kratkim delovanjem (vzdrževalno in olajševalno zdravljenje, ali shema MART).
English: If patients develop symptoms of asthma (wheezing and difficulty breathing) inhalation of a separate bronchodilator medicine with a rapid onset and short duration of action is advised for relief (rescue therapy).
Slovenian: Če se pri bolniku razvijejo simptomi astme (sopenje in oteženo dihanje), se za njihovo lajšanje priporoča inhalacija drugega bronhodilatatorja s hitrim začetkom in kratkim trajanjem delovanja (rešilno zdravljenje).
English: Questions and answers on Kantos Master and associated names (beclomethasone dipropionate / formoterol fumarate, inhaler)
Slovenian: Vprašanja in odgovori v zvezi z zdravilom Kantos Master in povezanimi imeni (beklometazon dipropionat / formoterol fumarat, inhalator)
English: It is inhaled once or twice a day, in order to keep asthma under control and reduce symptoms.
Slovenian: Za obvladovanje astme in zmanjšanje simptomov se zdravilo inhalira enkrat ali dvakrat na dan.